Lipopolysaccharide alters vasodilation to atrial natriuretic peptide via nitric oxide and endothelin-1: Time-dependent effects

European Journal of Pharmacology

Volumn 621, Issue 1-3, 2009, Pages 67-70

  Scicluna, Johann K ^a   Mansart, Arnaud ^a   Ross, Jonathan J ^a   Reilly, Charles S ^a   Brown, Nicola J ^a   Brookes, Zoë L S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Endothelin 1; Lipopolysaccharide; Nitric oxide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BACTERIUM LIPOPOLYSACCHARIDE; BOSENTAN; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SEPSIS; TIME; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN-1; HUMANS; LIPOPOLYSACCHARIDES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; SAPHENOUS VEIN; SULFONAMIDES; TIME FACTORS; VASODILATION; VENULES;

EID: 70349627864     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.029     Document Type: Article

References (31)

1. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 26 (2005) 1044-1059
2. Ángeles Costa M., Elesgaray R., Balaszczuk A.M., and Arranz C. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regul. Pept. 135 (2006) 63-68
3. Berbal J.E., Stavem K., Omland T., Hall C., and Smith-Erichssen N. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients. Acta Anaesthesiol. Scand. 52 (2008) 1265-1272
4. Brueckmann M., Huhle G., Lang S., Haase K.K., Bertsch T., Weiss C., Kaden J.J., Putensen C., Borggrefe M., and Hoffmann U. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112 (2005) 527-534
5. Connelly L., Madhani M., and Hobbs A.J. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice. J. Biol. Chem. 280 (2005) 10040-10046
6. Costa M.D., Bosc L.V., Majowicz M.P., Vidal N.A., Balaszczuk A.M., and Aranz C.T. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35 (2000) 1119-1123
7. Dauphinee S.M., and Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86 (2006) 9-22
8. Davenport A.P., O'Reilly G., and Kuc R.E. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br. J. Pharmacol. 114 (1995) 1110-1116
9. De Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
10. Dschietzig T., Alexiou K., Richter C., Bobzin M., Baumann G., Stangl K., and Brunner F. Endotoxin causes pulmonary hypertension by upregulating smooth muscle endothelin type-B receptors: role of aldose reductase. Shock 30 (2008) 189-196
11. 2+-independent activation of the endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. 96 (1999) 1123-1128
12. B receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R1168-R1177
13. Karimi G., Fatehi Z., and Gholamnejad Z. The role of nitric oxide and protein kinase C in lipopolysaccharide mediated vascular hyporeactivity. J. Pharm. Sci. 9 (2006) 119-123
14. Koichi A., Masakazu U., Masao E., and Masaki K. Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit. Care Med. 23 (1995) 1898-1906
15. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res. Cardiol. 99 (2004) 76-82
16. Liu S.F., Adcock M., Old R., Barnes P.J., and Evans T.W. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the rat. Crit. Care Med. 24 (1996) 1219-1225
17. Madhani M., Scotland R.S., MacAllister R.J., and Hobbs A.J. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br. J. Pharmacol. 139 (2003) 1289-1296
18. Madhani M., Okorie M., Hobbs A.J., and MacAllister R.J. Reciprocal regulation of human soluble and particulate guanylate cyclases in vivo. Br. J. Pharmacol. 149 (2006) 797-801
19. Mansart A., Ross J.J., Reilly C.S., Brown N.J., and Brookes Z.L. LPS abolishes extrasplenic vasoconstriction to atrial natriuretic peptide: the role of NO and endothelin 1. Shock 29 (2008) 675-680
20. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
21. Mulvany M.J., and Aalkjaer C. Structure and function of small arteries. Physiol. Rev. 70 (1990) 921-961
22. Murthy K.S., Teng B., Jin J., and Makhlouf G.M. Protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am. J. Physiol. 275 (1998) C1409-1416G
23. Pannen B.H., Bauer M., Zhang J.X., Robotham J.L., and M.G. Endotoxin pre-treatment enhances portal venous contractile response to endothelin-1. Am. J. Physiol. 270 (1996) H7-H15
24. Pollock D.M. Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function. Clin. Exp. Pharmacol. Physiol. 26 (1999) 258-261
25. Scicluna J.K., Mansart A., Ross J.J., Reilly C.S., Brown N.J., and Brookes Z.L. Reduced vascular response to phenylephrine during exposure to lipopolysaccharide in vitro involves nitric oxide and endothelin 1. Shock 29 (2008) 417-421
26. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89 (1994) 1203-1208
27. Sugiura M., Inagami T., and Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161 (1989) 1220-1227
28. Vo P.A., Lad B., Tomlinson J.A., Francis S., and Ahluwalia A. Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J. Biol. Chem. 280 (2005) 7236-7243
29. Wanecek M., Weitzberg E., Rudehill A., and Oldner A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 27 (2000) 1-15
30. Woods M., Bishop-Bailey D., Pepper J.R., Evans T.W., Mitchell J.A., and Warner T.D. Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. J. Cardiovasc. Pharmacol. 31 (1998) S348-S350
31. Yamaguchi N., Jesmin S., Zaedi S., Shimojo N., Maeda S., Gando S., Koyama A., and Miyauch T. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27 (2006) 2258-2270